Jennifer J. Huang, MD, PhD
Assistant Professor
Clinical Research Division, Fred Hutch
Dr. Jennifer Huang is a board-certified hematologist-oncologist whose research focuses on the use of combinatory therapy to improve CAR T-cell therapy outcomes in lymphoma and chronic lymphocytic leukemia, novel treatment strategies for patients with lymphoma and chronic lymphocytic leukemia, real-world outcomes of CAR T-cell therapy, the prediction of CAR T-cell toxicity, and the impact of BTK inhibitors on CAR T-cell efficacy and toxicity.
Other Appointments & Affiliations
Physician, Fred HutchPhysician
Fred Hutch
Assistant Professor
Division of Hematology and Oncology, University of Washington School of Medicine
Education
Fellowship, Hematology and Oncology, Fred Hutch/University of Washington
Residency, Internal Medicine, Washington University in St. Louis
PhD, Duke University School of Medicine
MD, Duke University School of Medicine
BS, Stanford University
Board Certification
Medical Oncology, 2025; Internal Medicine, 2022; American Board of Internal Medicine
Research Focus
Use of combinatory therapy to improve CAR T-cell therapy outcomes in lymphoma/chronic lymphocytic leukemia
Novel treatment strategies for patients with lymphoma/chronic lymphocytic leukemia
Real-world outcomes of CAR T-cell therapy
Prediction of CAR T-cell toxicity
Impact of BTK inhibitors on CAR T-cell efficacy and toxicity
Diseases Researched
Chronic lymphocytic leukemia
Hodgkin lymphoma
Lymphoma
Non-Hodgkin lymphoma
Clinical Expertise
Lymphoma
Chronic lymphocytic leukemia
CAR T-cell therapy